In the wake of headlined disease outbreaks in livestock, such as the H1N1 virus and Avian flu among several others, Dr. Ann Wilkinson, associate director of Global Alliances for Pfizer Animal Health in Christchurch, New Zealand, spoke at Wednesday morning’s session of the International Farm Management Association Congress on issues relating to advancements in animal health and food safety.
In her presentation, Dr. Wilkinson outlined several hot topics in the current livestock industry. With the occurrence of many transboundary diseases over the past several years, there are many human health issues closely related to livestock production. While an intense amount of scientific research goes into the development of new products and use of drugs such as vaccines, antibiotics and hormones, consumers tend to create their own perceptions of these developments and practices- regardless of the benefits and scientific logic backing such discoveries. These misconceptions have had a significant impact on the livestock sector, which accounts for 40 percent of agriculture’s Gross Domestic Product.
Dr. Wilkinson explained Pfizer, which is an animal pharmaceutical company with operations in 60 countries, has shifted their primary focus to disease prevention. “Prevention, prevention, prevention,” Dr. Wilkinson emphasized. Prevention is less costly and easier to implement in an operation as opposed to treating an entire herd. Over the years, less emphasis has been made towards antibiotic use and more focus has been given to prevention methods, including vaccination. Vaccinations have evolved rapidly over the years.
Read More